Eri S. Srivatsan
- Molecular Medicine top 0.5%
- Curcumin's Biomedical Applications 9
- Cancer Research top 2%
- Oncology top 2%
- Cancer-related Molecular Pathways 18
- Cancer Cells and Metastasis 6
- Otorhinolaryngology top 2%
- Molecular Biology top 5%
- Retinoids in leukemia and cellular processes 7
- RNA modifications and cancer 7
- RNA Interference and Gene Delivery 6
-
- Virus-based gene therapy research 7
-
- Neuroendocrine Tumor Research Advances 6
- Co-authors
- Marilene B. WangMysore S. VeenaReason WilkenHani RayessEric J. StanbridgePaul J. SaxonRita ChakrabartiSaroj K. Basak
- Partner nations
- United StatesSpainChina
In The Last Decade
Eri S. Srivatsan
72 papers receiving 3.9k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Molecular Medicine 882
- Cancer Research 750
- Oncology 1.0k
- Otorhinolaryngology 160
- Molecular Biology 2.1k
Countries citing papers authored by Eri S. Srivatsan
This map shows the geographic impact of Eri S. Srivatsan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eri S. Srivatsan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eri S. Srivatsan more than expected).
Fields of papers citing papers by Eri S. Srivatsan
This network shows the impact of papers produced by Eri S. Srivatsan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eri S. Srivatsan. The network helps show where Eri S. Srivatsan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eri S. Srivatsan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2022 | 20 | |
| 3 | 2022 | 10 | |
| 4 | 2020 | 22 | |
| 5 | 2017 | 33 | |
| 6 | 2016 | 18 | |
| 7 | 2014 | 5 | |
| 8 | 2013 | 45 | |
| 9 | 2013 | 3 | |
| 10 | 2011 | 96 | |
| 11 | 2010 | 99 | |
| 12 | 2009 | 61 | |
| 13 | 2009 | 50 | |
| 14 | 2008 | 86 | |
| 15 | 2004 | 14 | |
| 16 | 2001 | 12 | |
| 17 | 1999 | 1 | |
| 18 | 1997 | 56 | |
| 19 | Reply to Popescu and Zimonjic | 1996 | 1 |
| 20 | 1996 | 14 |
About Eri S. Srivatsan
Eri S. Srivatsan is a scholar working on Otorhinolaryngology, Molecular Medicine and Cancer Research, having authored 75 papers that have together received 4.0k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (18 papers), Curcumin's Biomedical Applications (9 papers), Virus-based gene therapy research (7 papers), Retinoids in leukemia and cellular processes (7 papers), RNA modifications and cancer (7 papers), RNA Interference and Gene Delivery (6 papers), Cancer Cells and Metastasis (6 papers) and Neuroendocrine Tumor Research Advances (6 papers). The work is most often cited by research in Molecular Medicine (882 citations), Cancer Research (750 citations) and Oncology (1.0k citations). Eri S. Srivatsan has collaborated with scholars based in United States, Spain and China. Frequent co-authors include Marilene B. Wang, Mysore S. Veena, Reason Wilken, Hani Rayess, Eric J. Stanbridge, Paul J. Saxon, Rita Chakrabarti, Saroj K. Basak, Alen N. Cohen and William F. Benedict. Their work appears in journals such as Genes Chromosomes and Cancer, The Laryngoscope, Genomics, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.